시장 소개
시티딘은 시토신이 α-N1 글리코시드 결합을 통해 리보스 고리(리보푸라노스라고도 알려짐)에 부착될 때 형성되는 뉴클레오시드 분자입니다. 시티딘은 RNA의 구성 요소입니다. 시티딘을 뇌의 세포외액으로 수송한 다음 뉴런과 신경교로 수송하는 것은 뇌에서 시티딘을 사용하는 데 필수적인 요구 사항입니다. 시티딘에 의한 핵산의 탈아미노화는 Ig 유전자의 다양화와 레트로바이러스 감염 억제의 기초가 되므로 숙주 방어에 중요한 것으로 보입니다. 활성화 유발 시티딘 데아미나제(AID)는 면역글로불린 유전자 내 데옥시시티딘(C)의 탈아미노화를 통해 항체 다양화를 유도합니다. 이는 항체 다양화를 중재하는 면역글로불린(Ig) 유전자좌에서 DNA 병변을 시작합니다. 유전성 AID 결함은 고-IgM 면역결핍을 유발합니다. AID는 또한 게놈 전반에 걸쳐 작용하여 암을 유발하는 돌연변이와 염색체 전위를 초래합니다. 시장 역학 시티딘 시장은 예측 기간 동안 상당한 발전을 보였습니다. 주요 추진 요인으로는 제약, 생명공학, 분자 과학, 유전체학 분야의 연구 개발 증가가 있습니다. 활성화 유도 시티딘 데아미나제(AID)는 항체 생산에서 확립된 역할로 알려져 있습니다. HIV(인간 면역결핍 바이러스), 인간 T세포 림프친화 바이러스(HTLV), B형 간염 바이러스(HBV), 인간 헤르페스 바이러스(HHV) 등과 같은 바이러스 감염의 발생률이 증가하면서 시장 성장을 주도하고 있습니다. 또한 전 세계적으로 약 20억 명이 감염되어 있고 2억 4천만 명 이상이 만성 간 감염으로 고통 받고 있습니다. B형 간염 바이러스 감염은 간경변증과 간세포암종을 포함한 급성 및 만성 간 질환을 유발할 수 있습니다. 기술 발전과 다가오는 수많은 연구 작업이 시장 성장을 촉진하고 있습니다. 그러나 연구 개발에 대한 높은 투자로 인해 시장 성장이 둔화될 가능성이 높습니다. 또한 통제되지 않은 시티딘 탈아미노화는 잘못 접힌 폴리펩티드, 우성 음성 단백질 또는 종양 억제 유전자의 돌연변이를 생성하여 종양 형성에 기여하여 시티딘 시장을 제한할 수 있습니다.시장 범위
“2028년 시티딘 시장 분석”은 글로벌 시장 동향 분석에 초점을 맞춘 헬스케어 산업의 생명공학에 대한 전문적이고 심층적인 연구입니다. 이 보고서는 유형, 애플리케이션 및 최종 사용자별로 상세한 시장 세분화를 통해 시티딘 시장을 설명합니다. 시티딘 시장은 예측 기간 동안 급격한 상승을 보일 것으로 예상됩니다. 이 보고서는 시티딘 시장의 주요 업체의 시장 상태에 대한 주요 통계에 초점을 맞추고 주요 추세와 기회를 제공합니다.시장 세분화
시장은 유형, 애플리케이션 및 최종 사용자를 기준으로 분류됩니다. 유형에 따라 시장은 시타라빈과 아자시티딘으로 분류됩니다. 응용 분야에 따라 시장은 암 치료와 급성 백혈병 치료로 분류됩니다. 최종 사용자를 기준으로 시장은 병원, 진료소 등으로 분류됩니다.지역적 프레임워크
이 보고서는 정량적 및 정성적 정보를 포함하여 업계에 대한 포괄적인 개요를 제공합니다. 이 보고서는 다양한 부문을 기반으로 하는 시티딘 시장의 개요와 예측을 제공합니다. 또한 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 등 5개 주요 지역에 대한 2020~2028년 시장 규모와 예측 추정치를 제공합니다. ) 및 중남미. 그런 다음 각 지역의 시장은 해당 국가와 부문으로 나뉩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측뿐만 아니라 해당 지역의 최근 동향과 기회도 다루고 있습니다. 이 보고서는 수요와 공급 측면 모두에서 시티딘 시장에 영향을 미치는 요인을 분석합니다. 또한 예측 기간 동안 시장에 영향을 미치는 시장 역학, 즉 동인, 제한 사항, 기회 및 미래 추세를 평가합니다. 보고서에는 또한 5개 지역 모두에 대한 자세한 PEST 분석이 포함되어 있습니다. 북미, 유럽, APAC, MEA 및 중남미는 해당 지역의 시티딘 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후입니다.시장 참가자
이 보고서에는 시티딘 시장의 주요 발전과 유기 및 무기 성장 전략이 포함되어 있습니다. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적 성장 전략에 중점을 두고 있습니다. 시장에서 관찰된 무기적 성장 전략에는 인수뿐만 아니라 파트너십과 협업도 포함되었습니다. 이러한 활동은 시장 참여자의 비즈니스 및 고객 기반 확대를 위한 기반을 마련했습니다. 전 세계적으로 시티딘 시장에 대한 수요가 증가함에 따라 시티딘 시장의 시장 참가자들은 향후 몇 년 동안 수익성 있는 성장 기회를 갖게 될 것으로 예상됩니다. 다음은 시티딘 시장에서 운영되는 일부 회사의 목록입니다. 이 보고서에는 SWOT 분석 및 시장 전략과 함께 시티딘 시장의 주요 플레이어 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 제공된 구성 요소 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발에 대한 정보를 통해 업계 선두 기업에 대해 설명합니다.- • HBio(그리스 바이오 클러스터) • Pfizer Inc. • Amgen Inc. • F. 호프만-라로슈 주식회사 • BIOGEN IDEC INC. • Cipla • AstraZeneca • Teva Pharmaceutical Industries Ltd. • Sigma-Aldrich, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. HBio (Hellenic Bio Cluster)
2. Pfizer Inc.
3. Amgen Inc.
4. F. Hoffmann-La Roche Ltd
5. BIOGEN IDEC INC.
6. Cipla
7. AstraZeneca
8. Teva Pharmaceutical Industries Ltd.
9. Sigma-Aldrich, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)